APVO (Aptevo) Margin operasi

Logo korporat perusahaan Aptevo Therapeutics, Inc. (APVO)

The potential of Aptevo Therapeutics (APVO) is based on ADAPTIR innovations, although a shortage of funds reduces actual profit. The operational efficiency of the business, as displayed on GURU.Markets, demonstrates volatility, where the value 0.00 describes the current yield level. Aptevo Therapeutics (APVO) seeks expansion into immunopharmacy through bispecific antibodies, however, geopolitical tension and sanctions seriously hinder international clinical trials and the logistics of biomaterials.

APVO - Rentabilitas operasi Aptevo ing rentang 04.07.2022 - 20.11.2026

Aptevo Therapeutics - rincian analitis lan metrik utama (APVO)

Produk merek Aptevo

Weak financial controls and regular share issuances by Aptevo Therapeutics (APVO) create risks for capital stability, despite the transparency of its biotechnological developments. An analysis of the profit share from core operations allows for an assessment of the operating cycle's efficiency before taxes and interest, where negative dynamics indicate a growing dependence on external financing and the risk of a liquidity gap.

Analisis pesaing Aptevo Therapeutics

ARGX (argenx N.V.) - Margin operasi|Rentabilitas dodolan operasi BioNTech Pharma BNTX|Margin dodolan operasi ABVX (ABIVAX)|Margin operasi ADMA Biologics, Inc. (ADMA)|Margin operasi PTGX (protagonist-inc.com)|IMVT: Rentabilitas dodolan miturut bathi operasi|KNSA - Rentabilitas operasi|GRFS: Rentabilitas operasi|ADPT (Adaptive Biotechnologies) - Margin dodolan operasi|Rentabilitas dodolan miturut bathi operasi CLDX|Margin dodolan operasi AUPH|BCRX (BioCryst Pharmaceuticals) - Rasio bathi operasi|Rentabilitas operasi Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Tingkat bathi operasi|Pharvaris N.V. - Margin dodolan operasi|Tingkat bathi operasi ABCL|TRML: Margin dodolan operasi|PGEN (Precigen) - Rentabilitas dodolan miturut bathi operasi|pharming.com (PHAR) - Rentabilitas operasi|Nektar Corp (NKTR) - Margin operasi|UPB (upstreambio.com) - Margin operasi|ZBIO: Tingkat bathi operasi|Margin operasi IMNM|Rentabilitas kegiatan operasi Gossamer Bio Inc|Margin operasi KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Margin bathi operasi|PVLA: Margin dodolan operasi|Margin bathi operasi SVRA|RIGL: Margin operasi|Rentabilitas dodolan miturut bathi operasi ANAB|ATXS (Astria Corp) - Margin operasi|Rentabilitas dodolan miturut bathi operasi ENGN (enGene Bio)|Margin operasi RAPT|Rentabilitas kegiatan operasi Aerovate Therapeutics|Rentabilitas operasi Aclaris Therapeutics Inc. ACRS|Rentabilitas kegiatan operasi Kyverna Therapeutics Inc. (KYTX)|TLSA - Rentabilitas operasi|CABA: Rentabilitas operasi|VTYX (Ventyx Biosciences, Inc.) - Margin dodolan operasi|THTX - Rentabilitas kegiatan operasi|AVTX (avalotx.com) - Margin operasi|Rentabilitas dodolan operasi Eledon Pharmaceuticals Inc. ELDN|Margin operasi AGEN|CLYM (Climb Bio, Inc.) - Tingkat bathi operasi|Rentabilitas operasi zurabio.com ZURA|ATYR - Margin dodolan operasi|Adagene Inc - Margin operasi|ImageneBio (IMA) - Margin dodolan operasi|Shattuck Therapeutics (STTK) - Rentabilitas operasi|Rentabilitas dodolan operasi Equillium Inc (EQ)|Margin dodolan operasi CNTB|Rentabilitas dodolan miturut bathi operasi IMUX (Immunic, Inc.)|Rentabilitas operasi Atara Biotherapeutics, Inc. (ATRA)|IFRX - Rentabilitas dodolan operasi|Rentabilitas kegiatan operasi XFOR|Rentabilitas kegiatan operasi Adicet (ACET)|CELU - Rentabilitas operasi|INMB (INmune Bio, Inc.) - Rentabilitas dodolan miturut bathi operasi|BRNS: Margin operasi|Kezar Life Sciences Inc. (KZR) - Margin operasi|Rentabilitas operasi SAB Biotherapeutics Inc|Margin operasi Akari Therapeutics, Plc|Rentabilitas operasi Enlivex Therapeutics Ltd (ENLV)|QTTB - Rentabilitas dodolan operasi|Margin operasi GOVX (GeoVax Corp)|Edesa Biotech (EDSA) - Rentabilitas dodolan operasi|iBio Corporation - Margin operasi|CARM (carismatx.com) - Rentabilitas dodolan miturut bathi operasi|XTLB (XTL Bio) - Margin dodolan operasi|Rentabilitas dodolan operasi Bolt Biotherapeutics Inc. (BOLT)|Margin dodolan operasi HCWB|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com